secwatch.observer — SEC 8-K summary
======================================

Issuer:     INOVIO PHARMACEUTICALS, INC. (INO)
CIK:        0001055726
Form:       8-K
Filed at:   2023-11-02T23:59:59+00:00
Accession:  0001193125-23-269347
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Inovio receives 180-day Nasdaq extension for minimum bid; stock transferred to Capital Market
--------------------------------------------------------------------------------

- Extension to April 29, 2024 to achieve $1.00 closing bid for 10 consecutive days.
- Common stock transferred from Nasdaq Global Market to Capital Market effective Nov 2, 2023.
- Failure to comply by April 29 may lead to delisting; company may appeal the determination.
- Company will consider reverse stock split among options to regain compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1055726/000119312523269347/0001193125-23-269347-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1055726/000119312523269347/d580286d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-269347

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer